Document is current
Any future updates will be listed below
-
Authors
Matta, Komodo
Viallon, Vivian
Chatziioannou, Anastasia Chrysovalantou
Robinot, Nivonirina
Wedekind, Roland
Dahm, Christina C.
Rostgaard-Hansen, Agnetha Linn
Tjønneland, Anne
Truong, Therese
Marques, Chloé
Frenoy, Pauline
Kaaks, Rudolf
Fortner, Renée Turzanski
Schulze, Matthias B.
Sieri, Sabrina
Fordellone, Mario
Tumino, Rosario
Ricceri, Fulvio
Braaten, Tonje
Nøst, Therese Haugdahl
Sánchez, Maria-Jose
Mokoroa-Carollo, Olatz
Colorado-Yohar, Sandra
Trobajo-Sanmartín, Camino
Papier, Keren
Harewood, Rhea
Tsilidis, Kostas
Vaccarella, Salvatore
Johansson, Mattias
Weiderpass, Elisabete
Delpierre, Cyrille
Lamy, Sebastien
Borch, Kristin Benjaminsen
Keski-Rahkonen, Pekka
Riboli, Elio
Freisling, Heinz
Gunter, Marc
Ferrari, Pietro
-
Funding
Funding for this research was provided by:
World Cancer Research Fund (IIG_FULL_2022_025, IIG_FULL_2022_025, IIG_FULL_2022_025, IIG_FULL_2022_025, IIG_FULL_2022_025, IIG_FULL_2022_025)
Centre International de Recherche sur le Cancer
- License Information
-
More Information
Article History
Received: 29 January 2025
Accepted: 9 April 2025
First Online: 16 June 2025
Declarations
:
: The approval of the European Prospective Investigation into Cancer and nutrition (EPIC) cohort by the IARC Ethics Committee (IEC) was initially given in 1995. The EPIC cohort and projects undertaken within the EPIC cohort, were successfully re-evaluated by the IEC in 2017 to support the requirement of ethics approval at the centres’ level, as requested by IARC-EPIC PIs and by the EPIC Steering Committee.
: Not applicable. This work does not contain any individual level data.
: The authors declare no competing interests.
